Location preference

Enter your country so we can show you products that are available for you.

woman looking at phone while connected to Spectra Optia device

Therapeutic Apheresis

More treatment options for more patients — that is what drives us at Terumo Blood and Cell Technologies.

We support a wide range of therapies and tools developed with insight from our experts and through our work within the industry. Whether you need the dependable performance of therapeutic apheresis, cell collection, or cell processing procedures, our solutions deliver choice and adaptability.

Our therapeutic apheresis portfolio is led by the Spectra Optia™ Apheresis System, our therapeutic apheresis and cell collection platform.* In addition, our customers enjoy ongoing support through training programs, education initiatives, scientific and clinical literature, and available analytic insights. 

With nearly 50 years of expertise as our foundation, we are proud to be a global apheresis leader and invite you to learn more about our solutions.

Global Therapy Innovations at Terumo Blood and Cell Technologies

Did you know our therapeutic apheresis and cell and gene therapy teams work closely together as part of one unified Global Therapy Innovations business unit? The infrastructure helps us better serve customers, integrate disease expertise across the patient treatment journey, and support the expansion of therapeutic possibilities.

A strategic partner dedicated to care access, innovation, service, and more

Our desire to help our customers elevate their operations, meet regulatory requirements, and achieve their goals has never been stronger.

Be sure to learn more about how we empower our customers and help them realize their missions, including through providing:

Contact us to discuss how you can advance apheresis. 

Disclaimers and notes

*Product and protocol availability varies by country. 

To top